Compositions and methods for treatment of skin-related diseases and promoting dermatological health

Abstract

The present disclosure relates to dietary supplements, for improving dermatological health. In embodiments, the composition is comprised of D-Biotin, grape seed extract, superoxide dismutase, zinc, Vitamin C, Lactobacillus Plantarum, Lactobacillus Reuteri, Lactobacillus Rhamnosus , or combinations/sub-combinations thereof.

What is claimed is: 
     
         1 . A method for treating a skin-related condition by administering an effective amount of a composition to a patient, wherein the composition comprises:
 between about 1,000 mcg and about 3,000 mcg of D-Biotin;   between about 50 mg and about 300 mg of a first blend, comprising:
 grape seed extract; 
 superoxide dismutase; 
 Zinc; and 
 Vitamin C; 
   between 1 Billion CFU/g and 5 Billion CFU/g of a second blend, comprising:
   Lactobacillus Plantarum;    
   Lactobacillus Reuteri ; and 
   Lactobacillus Rhamnosus.    
   
     
     
         2 . The method of  claim 1 , wherein the composition is administered orally in the form of a capsule. 
     
     
         3 . The method of  claim 1 , wherein the first blend of grape seed extract, superoxide dismutase, Zinc and Vitamin C comprises about 150 mg of the composition administered to the patient. 
     
     
         4 . The method of  claim 1 , wherein the grape seed extract in the first blend is a French grape seed extract. 
     
     
         5 . The method of  claim 1 , wherein the superoxide dismutase in the first blend if derived from melon. 
     
     
         6 . The method of  claim 1 , wherein the second blend of  Lactobacillus Plantarum, Lactobacillus Reuteri  and  Lactobacillus Rhamnosus  comprises about 3 Billion CFU/g of the composition administered to the patient. 
     
     
         7 . The method of  claim 1 , wherein the D-Biotin comprises about 2,000 mcg of the composition administered to the patient. 
     
     
         8 . The method of  claim 1 , wherein the composition administered to the patient does not comprise additives selected from the group consisting of gluten, wheat, egg, peanuts, tree nuts, dairy, sugar, com, soy, artificial colors, preservatives, fish and shellfish. 
     
     
         9 . The method of  claim 1 , wherein the composition administered to the patient further comprises at least one palatability agent. 
     
     
         10 . The method of  claim 9 , wherein the palatability agent is selected from the group consisting of plant oils, plant hydrolysates, yeast, and yeast hydrolysates. 
     
     
         11 . A method for treating a skin-related disease, comprising:
 administering an effective amount of a composition to a patient, wherein the composition comprises:   about 2,000 mcg of D-Biotin;   about 150 mg of a first blend, wherein the first blend comprises:
 grape seed extract; 
 superoxide dismutase; 
 Zinc; and 
 Vitamin C; 
   about 3 Billion CFU/g of a second blend, wherein the second blend comprises:
   Lactobacillus Plantarum;    
   Lactobacillus Reuteri ; and 
   Lactobacillus Rhamnosus.    
   
     
     
         12 . The method of  claim 11 , wherein the composition is administered orally in the form of a capsule, tablet, lozenge or powder. 
     
     
         13 . The method of  claim 11 , wherein the grape seed extract in the first blend is a French grape seed extract. 
     
     
         14 . The method of  claim 11 , wherein the superoxide dismutase in the first blend if derived from melon. 
     
     
         15 . The method of  claim 11 , wherein the composition administered to the patient does not comprise additives selected from the group consisting of gluten, wheat, egg, peanuts, tree nuts, dairy, sugar, com, soy, artificial colors, preservatives, fish and shellfish. 
     
     
         16 . The method of  claim 11 , wherein the composition administered to the patient further comprises at least one palatability agent. 
     
     
         17 . The method of  claim 16 , wherein the palatability agent is selected from the group consisting of plant oils, plant hydrolysates, yeast, and yeast hydrolysates. 
     
     
         18 . The method of  claim 11 , wherein the composition is administered orally to the patient between 1-4 times each day. 
     
     
         19 . The method of  claim 11 , wherein the skin-related disease is selected from the group consisting of skin cancer, acne, eczema, psoriasis, rosacea, ichthyosis, vitiligo, hives, dermatitis, and seborrheic dermatitis.